期刊文献+

新型长效干扰素α_(2b)对恒河猴的毒性研究 被引量:1

Toxicity Study of New Long-acting Interferon α_(2b) in Rhesus Monkey
原文传递
导出
摘要 目的观察白蛋白-干扰素融合蛋白Woferon皮下注射给药对恒河猴的毒性作用。方法恒河猴皮下注射Woferon5周毒性试验,观察给药后动物的临床行为、心电图、外周血象、血液生化、尿液等指标的变化。结果恒河猴皮下注射高剂量(800μg/kg)Woferon引起可逆性白细胞(WBC)下降(P<0.05)和天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)升高;高剂量组(800μg/kg)、中剂量组(200μg/kg)恒河猴产生可逆的血小板(Plt)下降(P<0.05)。结论Woferon给恒河猴皮下注射5周除有一过性外周血WBC、Plt下降外,未见其他明显毒性反应。 Objective To observe the toxic effects of the new type of albumin-interferon Woferon in Rhesus monkeys.Methods Subcutaneous injection of Rhesus monkeys Woferon for 5 weeks,the animals' behavior,electrocardiogram(ECG),hematology,biochemistry and urine were observed.Results The subcutaneous injection of high-dose Woferon(800 μg/kg),rhesus monkeys cause white blood cells(WBC)decrease(P0.05)and aspartate aminotransferase(AST),and alanine aminotransferase(ALT)increase.In the high-dose group middle dose group(200μg/kg)rhesus monkeys had a reversible platelet(Plt)decrease(P0.05).Conclusion Woferon subcutaneous injection to rhesus monkeys for five weeks will cause the revisable decrement of WBC Plt,and no other significant toxicity occurs.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2010年第1期66-68,共3页 Suzhou University Journal of Medical Science
关键词 恒河猴 Woferon 毒性作用 rhesus monkey woferon toxicity
  • 相关文献

参考文献5

  • 1Osborn BL, Olsen HS, Nardelli B, et al. Pharmacokinetic and pharmacodynamic studies of a human serum albumininterferon-α fusion protein in cynomolgus monkeys [ J ]. J Pharmacol Exp Ther, 2002,303 ( 2 ) :540 - 548.
  • 2Bain VG, Kaita KD, Yoshida EM, et al. A Phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients [ J]. J Hepatol, 2006, 44 (4) :671 - 678.
  • 3John M Kikwood, Catherine Bender, Sanjiv Agarwala, et al. Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy [ J ]. Jounal of Clinical Oncology, 2002, 17 (20) :3703 - 3718.
  • 4Axel Hauschild, Helen Gogas, Ahmad Tarhini, et al. Practical guidelines for the management of interferon-α-2b side effects in patients receiving adjuvant treatment for melanoma [ J ]. Wiley InterScience ,2008,5 (112) :982 - 993.
  • 5魏荣堂,魏永利.干扰素的不良反应[J].实用医技杂志,2005,12(08B):2310-2312. 被引量:12

二级参考文献2

共引文献11

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部